Evidence map›Paper›PMID 18672221›Full record

ReviewAmerican journal of ophthalmology2008

The need for standardization of antiretinal antibody detection and measurement.

Farzin Forooghian, Ian M Macdonald, John R Heckenlively, Elise Héon, Lynn K Gordon, John J Hooks, Barbara Detrick, Robert B Nussenblatt

Open access · greenAbstract readReview
In one paragraph

Review in American journal of ophthalmology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 68 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. B Cell Anomalies in Autoimmune Retinopathy (AIR).Investigative ophthalmology & visual science · 2017
    Article
  11. Article
  12. Article
  13. Article
  14. The enigma of autoimmune retinopathy.International ophthalmology clinics · 2015
    Review
  15. Autoimmune retinopathy.American journal of ophthalmology · 2014
    Review
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

Farzin ForooghianDivision of Epidemiology and Clinical Research, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Ian M Macdonald
John R Heckenlively
Elise Héon
Lynn K Gordon
John J Hooks
Barbara Detrick
Robert B Nussenblatt
National Eye Institute · USJohns Hopkins University · USNational Institutes of Health · USUniversity of Michigan–Ann Arbor · USUniversity of Toronto · CAVA Greater Los Angeles Healthcare System · US

Funding

Diagnosis And Treatment Of Ocular Inflammatory Disease (uveitis)ZIAEY000356 · NEI · NATIONAL EYE INSTITUTE · PI SEN, HATICE · 2009 to 2016
$2.7M
Cellular and molecular mechanisms in Age Related Macular Degeneration & UveitisZIAEY000464 · NEI · NATIONAL EYE INSTITUTE · PI CHAIGNE-DELALANDE, BENJAMIN · 2009 to 2016
$2.4M
VIRUS INFECTIONS IN THE EYEZ01EY000240 · NEI · NATIONAL EYE INSTITUTE · PI HOOKS, JOHN · 1987 to 2008
$1.8M
Diagnosis And Treatment Of Ocular Inflammatory Disease (uveitis)Z01EY000356 · NEI · NATIONAL EYE INSTITUTE · PI NUSSENBLATT, ROBERT B. · 2000 to 2008
$986k
Studies Of The Bioregulatory Aspects Of The Retinal Pigment Epithelial CellZIAEY000233 · NEI · NATIONAL EYE INSTITUTE · PI HOOKS, JOHN · 2009 to 2010
$612k
Intramural NIH HHS Z01 EY000356
6 · The paper itself

Abstract

purposeTo review the current literature on the detection and measurement of antiretinal antibodies.

designCollaborative essay.

methodsLiterature review and interpretation.

resultsThere is strong evidence to suggest a role for antiretinal antibodies, particularly those targeting recoverin and alpha-enolase, in the pathogenesis of autoimmune retinopathy (AIR). Additionally, numerous other autoantibodies have been described as putative mediators of retinal degeneration and more remain to be discovered. However, assay methods described in the literature by many laboratories for the detection of circulating antiretinal antibodies have been varied and diverse, making it difficult to interpret and compare their results.

conclusionsThere is currently little standardization of laboratory methods used to detect and monitor antiretinal antibodies. To measure and monitor levels of circulating antiretinal antibodies optimally in patients with AIR, development of standardized assays with stringent internal controls is required. A multicenter collaborative and validation effort is encouraged to reach a consensus on this issue.

Indexed as

AutoantibodiesAutoantigensAutoimmune DiseasesBlotting, WesternEnzyme-Linked Immunosorbent AssayHumansImmunohistochemistryImmunologic TestsPhosphopyruvate HydrataseRecoverinReproducibility of ResultsRetinaRetinal DiseasesAutoantibodiesAutoantigensPhosphopyruvate HydrataseRecoverin

Identifiers

PMID18672221
PMCPMC2548286
OpenAlexW2029292560

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.